UBS downgraded enGene (ENGN) to Neutral from Buy with a price target of $7, down from $34, after assuming coverage of the name. enGene’s lead program, detalimogene, previously demonstrated lower ...
After hours: February 14 at 4:26:03 PM EST Loading Chart for ENGN ...
After hours: February 14 at 4:26:03 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback